Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate

Sep 11, 2026

With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S. commercial footprint and a new IRE technology partnership, $BDMD is building a broader minimally invasive medical technology platform

NEW CITY, N.Y. - Sept. 11, 2026 - PRLog -- Baird Medical Investment Holdings Ltd. (N A S D A Q: BDMD) $BDMD is entering an increasingly interesting stage of its corporate evolution. What was once primarily a China-focused microwave ablation company is now pursuing a much broader strategy: expand internationally, establish a meaningful U.S. commercial presence, diversify its technology portfolio and turn its minimally invasive ablation expertise into a global medical technology platform.

The company's latest financial announcement may be the clearest indication yet that this strategy is beginning to produce measurable results.

On September 3, Baird Medical reported approximately $9.9 million in revenue for the first six months of 2026, representing a 24.6% increase over the approximately $8.0 million generated during the comparable period of 2025. Even more noteworthy, approximately two-thirds of first-half revenue came from outside mainland China, with Hong Kong and the United States representing the principal contributing regions.

For investors watching BDMD's international transition, that geographic shift could be one of the most important developments of the year.

The Numbers Are Moving in the Right Direction

Baird's first-half results contained several encouraging operating signals:
  • Revenue increased 24.6% to approximately $9.9 million
  • Gross profit increased 32% to approximately $8.6 million
  • Gross margin improved to 87.0% from 82.1%
  • Operating expenses fell dramatically to $7.8 million from $17.0 million
  • Net income improved to approximately $14,000 from an $11.4 million loss
  • Adjusted EBITDA improved to approximately $4.0 million from negative $3.3 million
  • Approximately 27% of first-half revenue came from the United States, compared with less than 2% in the first half of 2025.

The transformation in U.S. contribution is particularly interesting.

Baird isn't simply talking about entering the American market anymore. The company says its U.S. commercial expansion is progressing ahead of plan, with an expanded sales team providing coverage across multiple key territories. Management is also working toward additional product submissions and regulatory clearances.

That creates an intriguing potential growth equation: if U.S. adoption continues to build while the company simultaneously expands internationally, BDMD could become increasingly diversified geographically.

From China Headwinds to a Global Strategy


The importance of this transition becomes clearer when looking at 2025.

Baird reported full-year 2025 revenue of approximately $22.5 million, down from $37.0 million in 2024, with the company attributing much of the decline to policy-driven pricing pressure and reduced procurement activity in mainland China. Rather than remain dependent upon that market, Baird accelerated its geographic diversification strategy.

That strategy now appears to be gaining traction.

In June, Baird established its global headquarters in New York City, reinforcing its focus on U.S. commercial expansion. The company also appointed experienced med-tech executive Mark Saxton to lead Baird Medical's U.S. operations and commercial ramp.

The significance goes beyond a change of address. New York provides Baird with a more prominent base for its U.S. operations, while the expanding sales organization and physician relationships are designed to support broader adoption of its minimally invasive technology.

International Expansion Continues to Stack Up

Baird's global expansion is also becoming increasingly visible.

In June, physicians in Vietnam and Argentina completed their first microwave ablation procedures using Baird Medical's technology, providing evidence of progression from regulatory and market-entry activity toward actual clinical utilization.

Then, on August 20, Baird announced that Pakistan's Drug Regulatory Authority of Pakistan (DRAP) had granted product registrations for its BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle.

Those registrations build upon Baird's existing Pakistani presence, including earlier regulatory approvals and commercial availability at the Armed Forces Institute of Radiology & Imaging.

For an emerging medical technology company, each new market can potentially expand the addressable customer base while also building clinical experience, physician familiarity and distribution infrastructure.

A Potentially Bigger Story: IRE Technology

Perhaps the most intriguing recent strategic development came August 10.

Baird announced a strategic cooperation agreement with Alpmed, a developer of irreversible electroporation, or IRE, technology.

IRE is a non-thermal ablation technology that uses electrical pulses to destroy targeted tissue while seeking to preserve surrounding structures such as blood vessels and nerves. The companies intend to combine Alpmed's IRE expertise with Baird's regulatory and global commercialization capabilities.

The planned first co-developed product is intended for soft-tissue solid tumors involving the liver, breast, thyroid and prostate.

More importantly for investors, Baird and Alpmed plan to submit a 510(k) application to the FDA by the end of 2026, with potential FDA clearance in 2027.

Baird is expected to lead global regulatory approval efforts and holds worldwide commercialization rights for the IRE product.

That could potentially broaden BDMD's opportunity substantially beyond its established microwave ablation business.

And AI Could Add Another Layer

Baird is simultaneously developing an AI-driven surgical software platform designed to automate clinical workflows including anatomical mapping, treatment planning and procedural simulations.

The company announced in March that it had completed development of its cross-platform surgical software and had begun registration efforts in the United States, European Union and China. The software is also designed to integrate with Baird's planned fully automated surgical robotic system.

Taken together, the company's development pipeline points toward something potentially larger than a single-product medical device company:

MWA + IRE + AI software + robotic ablation + international commercialization.

That combination is what makes BDMD particularly interesting to watch.

What Could Investors Be Watching Next?

Several potential catalysts now stand out:
  • Continued growth in U.S. MWA utilization and physician adoption
  • Additional international regulatory approvals and commercial launches
  • Progress toward the planned IRE 510(k) submission
  • Additional product regulatory submissions
  • Expansion of Baird's U.S. sales organization
  • Further evidence that positive earnings and EBITDA can be sustained
  • Development and regulatory progress for the company's AI-powered and robotic technologies

There are, of course, meaningful risks. Baird's first-half financial figures are preliminary and unaudited, and the company remains exposed to regulatory, competitive, financing, geopolitical and execution risks. Its history also demonstrates how quickly policy and pricing conditions can affect medical-device businesses.

But the current story is undeniably becoming more interesting.

The Bottom Line

Baird Medical appears to be moving through a significant transition — from a company heavily exposed to the Chinese market toward a more diversified, international minimally invasive medical technology business.

The latest numbers provide tangible evidence of that shift: revenue is growing, margins have improved, operating expenses have fallen sharply, the company has returned to approximately breakeven net income, and U.S. revenue has gone from a negligible portion of the business to approximately 27% of first-half revenue.

At the same time, Pakistan, Vietnam and Argentina are adding to the company's international footprint, while the planned IRE program and AI/robotics initiatives introduce potentially much larger opportunities beyond its current MWA platform.

For investors willing to look beyond the immediate quarter, BDMD presents an intriguing developing story: a relatively small publicly traded medical technology company attempting to build a global platform around minimally invasive ablation.

The real question now may not be whether Baird Medical has opportunities.

It may be how successfully the company can convert those opportunities into sustained U.S. adoption, recurring international revenue and a broader portfolio of commercially successful technologies.

For BDMD investors, the next several quarters could be particularly important.

For more information on BDMD visit: https://ir.bairdmed.com/ or https://www.compasslivemedia.com/bdmd/

Media Contact

Company Name: Baird Medical Investment Holdings Ltd. (Nas daq: BDMD)
Contact Person: Lee Roth, Burns McClellan for Baird Medical
Email: [email protected]
Phone: (86) 20 8218-5926
Country: China

Contact
CorporateAds
***@gmail.com

Photos: (Click photo to enlarge)




Source: CorporateAds

Read Full Story - Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate | More news from this source

Press release distribution by PRLog
MORE NEWS
Lending services for foreign nationals becomes next battleground for banks
Oct 20, 2026
Lending services for foreign nationals becomes next battleground for banks

Korean banks are expanding lending services to foreign residents as they seek to tap a growing customer base beyond traditional services such as bank accounts and overseas remittances, industry officials said Tuesday. The shift reflects intensifying competition for foreign customers, including migrant workers and international students, as lenders broaden their offerings to include loans. Major commercial banks have rolled out dedicated loan products for foreign borrowers in recent years. Hana Bank launched the Hana Foreigner EZ Loan in August for E-7 and E-9 visa holders, offering loans of up to 10 million won ($7,500) for terms of up to 30 months. Shinhan Bank introduced its SOL Global Loan with a maximum limit of 20 million won, while NH NongHyup Bank rolled out its K-Foreigner Credit Loan, which offers loans of up to 30 million won to foreign borrowers. Regional lenders have established an early foothold in the market. Jeonbuk Bank, based in North Jeolla Province, launched loan services for foreign customers in 2016 and introduced online lending services in 2023. Kwangju Bank, BNK Kyo

Hanwha Life expands youth financial education program to Indonesia
Oct 20, 2026
Hanwha Life expands youth financial education program to Indonesia

Hanwha Life Insurance is expanding its financial education initiatives to Indonesia, aimed at helping teenagers build financial literacy in an increasingly digital landscape, the insurer said Tuesday. Developed with the international nonprofit Save the Children, the program is based in Indonesia’s Bandung, where young people face risks, including illegal lending and online scams and gambling, as digital financial services become more widespread. The project builds on Hanwha Life’s work in Vietnam last year, when it provided education to financially vulnerable groups, including women and young people. The Bandung program is designed to continue beyond its initial run by training local students and teachers to lead financial education. Ten high school students at each participating school are chosen to teach their peers, with support from university mentors at the Bandung Institute of Technology. Teachers are also receiving training to deliver lessons themselves. It has so far reached around 600 teenagers and 100 university students and teachers. In January, Hanwha Life plans to bring 2

Coway offers tailored mattress options for different sleeping habits
Oct 20, 2026
Coway offers tailored mattress options for different sleeping habits

Coway is promoting three mattresses under its BEREX brand to meet diverse sleeping preferences, offering options for people with different sleeping postures and couples who prefer different levels of firmness. The company said its lineup is designed to accommodate differences in body shape and sleeping habits, as Koreans tend to get relatively little sleep, making it increasingly important for consumers to improve their sleep quality. According to a 2024 survey by the Korean Society of Sleep Research, Koreans sleep an average of six hours and 58 minutes a day, placing the country among the lowest-ranked OECD members in terms of sleep duration. With limited hours of sleep, more consumers are seeking better-quality rest, making it increasingly important for mattress makers to address their diverse needs. For people who sleep on their backs or prefer firmer support, Coway recommends the BEREX Modi Mattress, which uses individually pocketed signature springs made with high-strength steel wire from POSCO for durability and stability, along with Contour 7-Zone Foam designed to distribute body

Microsoft-IITP program helps Korean AI talents tap into global research resources
Oct 20, 2026
Microsoft-IITP program helps Korean AI talents tap into global research resources

Budding artificial intelligence (AI) researchers presented the results of their work during an internship program jointly organized by Microsoft Research and the Institute of Information & Communications Technology Planning & Evaluation (IITP), showcasing new findings in areas such as visual agentic AI, brain-inspired AI, AI-native systems and spatial intelligence. Microsoft, IITP and the Ministry of Science and ICT jointly held the 2026 Korea Day presentation event at Microsoft Korea Office in central Seoul, Tuesday, with over 100 students, mentors and officials from Microsoft Research Asia (MSRA) and IITP attending. IITP is the policy-planning and management arm of the ministry. “By embracing interdisciplinary and cross-boundary research rooted in Asia Pacific, we aim to define the new paradigm of computing and AI for the better,” Microsoft Research Accelerator Director Lee Mi-ran said. “Our collaboration with Korea is not a series of one-off events. It has been built steadily over more than 20 years … Government provides the framework, universities provide the talent and idea

Mercedes-Benz Korea turns to affordable CLA EV amid falling sales
Oct 20, 2026
Mercedes-Benz Korea turns to affordable CLA EV amid falling sales

Mercedes-Benz Korea is betting that a more affordable all-electric CLA sedan will revive its flagging electric vehicle (EV) business in the country, as Tesla and Chinese rivals gain ground in one of Asia’s most competitive imported-car markets. The German luxury automaker introduced the all-new electric CLA and GLC on Monday, with the entry-level CLA coupe-type sedan priced from 52.9 million won ($40,000). The pricing marks a major shift from Mercedes-Benz’s traditional premium positioning, placing its new electric sedan closer to mass-market alternatives, including Tesla’s Model Y, which starts at 49.99 million won in Korea. The Model Y was the country’s best-selling vehicle last month, largely due to its competitive pricing. The launch of the price-competitive CLA comes as Mercedes-Benz struggles to rev up sluggish EV sales. The company’s electric car lineup, previously a major source of growth, has lost momentum following the August 2024 fire involving a Mercedes-Benz EQE sedan in an underground parking garage in Incheon. Mercedes-Benz’s EV sales in Korea reached a peak of

LIG D&A, Doosan Enerbility team up to develop missile, aircraft engines
Oct 20, 2026
LIG D&A, Doosan Enerbility team up to develop missile, aircraft engines

LIG Defense & Aerospace (LIG D&A) and Doosan Enerbility have agreed to jointly develop engines for guided missiles and aircraft, combining the defense firm’s missile expertise with the power equipment maker’s turbine technology, LIG D&A said Tuesday. The two companies signed a memorandum of understanding on Monday at Doosan Tower in the Bundang area of Seongnam, Gyeonggi Province. The ceremony was attended by the head of LIG D&A’s missile systems business division, the head of Doosan Enerbility’s power service business group and other senior officials. LIG D&A, formerly known as LIG Nex1, is Korea’s leading maker of guided weapons, which are missiles and other munitions that can be steered toward a target after launch. The company changed its name in March to reflect its expansion into aerospace. Doosan Enerbility, best known for building power plant equipment, is developing next-generation aircraft propulsion technology based on expertise built up in gas turbines for electricity generation. Under the agreement, the companies will pair LIG D&A’s capabilities in developing and

HD KSOE wins $1.4 bil. order from HMM for 8 container ships
Oct 20, 2026
HD KSOE wins $1.4 bil. order from HMM for 8 container ships

HD Korea Shipbuilding & Offshore Engineering (HD KSOE) said Tuesday it has secured a 1.91 trillion-won ($1.44 billion) order from South Korean shipping company HMM to build eight liquefied natural gas (LNG) dual-fuel container ships. HD KSOE, the shipbuilding subholding company of HD Hyundai, said the vessels will be equipped with engines capable of running on both LNG and conventional marine fuels. The 13,000-twenty-foot-equivalent-unit (TEU)-class ships will measure 337 meters in length, 51 meters in width and 27.9 meters in height. Two vessels will be built at affiliate HD Hyundai Heavy Industries' shipyard in the southeastern city of Ulsan. The remaining six will be constructed at HD Hyundai Samho's shipyard in the southwestern city of Yeongam. All eight vessels are scheduled to be delivered to HMM in stages by 2029. With the latest contract, HD KSOE has secured orders worth $20.19 billion for 182 vessels so far this year, achieving 86.6 percent of its annual order target.

Innocean's overseas units win 7 honors at US, Middle East ad awards
Oct 20, 2026
Innocean's overseas units win 7 honors at US, Middle East ad awards

Innocean, the advertising affiliate of Hyundai Motor Group, said Tuesday its overseas units have won seven honors at advertising awards in the United States and the Middle East. Innocean USA received two silver awards at the 2026 Jay Chiat Awards, hosted by the American Association of Advertising Agencies. The 29-year-old competition judges anonymized case studies on how strategic thinking delivered real business results. Hyundai Motor’s “IONIQ 9 Escape Garage” won silver in the influencer and creator strategy category, while Genesis’ “A New Beginning in Luxury” took silver in automotive strategy. Both were produced with Canvas Worldwide, Innocean’s U.S. media subsidiary. In the IONIQ 9 campaign, three creator families used the electric SUV’s interior space, seating and EV features to complete escape-room missions, drawing 8.6 million views. Innocean USA’s social media team was also named in the agency social media category of marketing publication Adweek’s Team Visionary Awards. Its work included “Hyundai Jingle Road Trip,” which turned a jingle TikTok users made

Hankook Tire extends Ballon d'Or partnership for 3rd straight year
Oct 20, 2026
Hankook Tire extends Ballon d'Or partnership for 3rd straight year

Hankook Tire is extending its presence in global football as it returns for a third consecutive year as an official sponsor of the Ballon d’Or, with this year’s ceremony marking the award’s 70th anniversary and its first edition in London. Hankook Tire & Technology, part of Hankook & Company Group, said it will sponsor the 2026 Ballon d’Or ceremony, scheduled for Oct. 26 at the London Palladium Theatre. Established in 1956 by French football magazine France Football, the Ballon d’Or is widely regarded as one of the highest individual honors in football, recognizing players for their performances during the previous season. Since 2024, France Football, part of the L’Équipe Group, has organized the awards in partnership with UEFA. This year’s ceremony moves to London for the first time, commemorating seven decades since the award’s founding and paying tribute to Stanley Matthews, the England international who won the inaugural Ballon d’Or in 1956. The ceremony will also reveal the successors to last year’s winners, Aitana Bonmatí and Ousmane Dembélé. Hankook Tire said

CJ ONE expands membership perks to public transit with new partnership
Oct 20, 2026
CJ ONE expands membership perks to public transit with new partnership

CJ ONE is bringing its rewards program onto public transit, joining forces with mobility fintech company E-Dreams to connect travel, shopping and dining through a single membership platform for Korean and international customers. CJ OliveNetworks, which operates the lifestyle membership service, said Tuesday it had signed a memorandum of understanding with E-Dreams to expand membership benefits into mobility and payment services. The agreement was signed Monday at E-Dreams’ headquarters in central Seoul, with Yoo In-sang, CEO of CJ OliveNetworks, and Lee Jung-hwan, CEO of E-Dreams, in attendance. The first initiative will be a transportation card designed for international visitors to Korea, scheduled for release by the end of 2026. The card will combine E-Dreams’ public transportation payment functions with CJ ONE membership benefits, allowing foreign tourists to use buses and subways while earning and redeeming points at participating businesses. Distribution is planned through E-Dreams’ existing retail network, including airports and convenience stores. The partnership follows CJ

Samsung Bioepis secures 10-year exclusive drug supply deal in Brazil
Oct 20, 2026
Samsung Bioepis secures 10-year exclusive drug supply deal in Brazil

Samsung Bioepis has secured a decade-long exclusive supply deal for a rare disease treatment in Brazil, strengthening its position in Latin America’s largest pharmaceutical market while opening a new chapter in its partnership with the Brazilian government. The Korean biopharmaceutical company said Tuesday it had signed a local partnership agreement to supply SB12, a biosimilar of Soliris with the active ingredient eculizumab, to Brazil’s Ministry of Health. SB12 is used to treat rare conditions including paroxysmal nocturnal hemoglobinuria, a blood disorder, and atypical hemolytic uremic syndrome, which can damage blood cells, kidneys and other organs. Brazil’s health regulator, the National Health Surveillance Agency, known as ANVISA, approved the drug in December 2024. The Brazilian eculizumab market was worth about $170 million (250 billion won) last year, according to the company, which expects the 10-year exclusive supply agreement to provide a stable source of revenue. Under the government-led Productive Development Partnership program, Samsung Bioepis will work with Brazilia

GS Global invests in carbon credit firm to expand trading business
Oct 20, 2026
GS Global invests in carbon credit firm to expand trading business

GS Global is expanding into carbon credit trading through an equity investment in Hooxi Partners, a Korean carbon credit specialist, seeking to monetize emissions reductions from its existing eco-friendly businesses. GS Global said Tuesday that the investment would establish a strategic partnership, combining Hooxi Partners’ carbon reduction expertise with GS Global’s global network and trading capabilities. The investment comes as Korea's fourth emissions trading scheme, covering 2026-2030, takes effect. Tighter emissions caps, expanded paid allocations and stricter global carbon regulations are raising the cost of securing carbon credits and increasing exposure to price volatility. GS Global aims to turn carbon credits into a new growth engine. Founded in 2021, Hooxi Partners offers services ranging from carbon credit methodology development and emissions reduction project management to securing Korean Offset Credits (KOCs) and forward trading. The company focuses on transportation-related emissions reduction projects, particularly the transition to electric vehicles. It also oper

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

About Us

Always dynamic, always updated, The Witness Daily ensures minute-by-minute update to the most pressing issues, curated specifically to cater to critical newsreaders of our time.

Copyright © 2015 - 2026 Redshift Daily. All Rights Reserved.